PMC Biogenix, the leading sustainable producer of specialty fatty amides and high-value biobased products, announces the construction and expansion of its new Armoslip® facility in Gyeongju, South Korea allowing for a production capacity increase of 50%. Construction will begin late 2024 with new supply available by mid-2026.

“We are excited to announce plans to build a new facility in Gyeongju. This investment will allow us to significantly increase production capacity to meet growing customer demand for our Armoslip products,” said Debtosh Chakrabarti, President, PMC Group N.A., Inc. Adding, “This project solidifies our commitment as the industry leader, delivering products and solutions to our customers, as well as to the local Gyeongju community. We appreciate the continued support of the Gyeongju, South Korea local government, community, and our customers.”

As part of PMC’s ongoing commitment of ensuring long-term sustainability and success of the Biogenix business world-wide, a comprehensive strategic product review of the Memphis facility was conducted resulting in a focus on higher value Fatty Amides and Bisamides (Armoslip® and Kemamide®), Glycerol Esters (Kemester®), Metallic Stearates (Lubrazinc®), and Specialty Esters (Kemester®) and the decision to exit the merchant market for certain commodity bulk fatty acids. This restructuring will enhance operational efficiencies, focus on core strengths, align resources with market demand and bolster PMC’s oleochemical derivatives business.

About PMC
PMC Group is a growth oriented, diversified, global chemicals and plastics company dedicated to innovative solutions to everyday needs in a broad range of end markets including plastics, consumer products, electronics, paints, packaging, personal care, food, automotive and pharmaceuticals. The Company was built on a sustainable model of growth through innovation while promoting social good. PMC operates from a global manufacturing, innovation and marketing platform with facilities in the Americas, Europe and Asia. More information about PMC and its activities around the world can be found at www.pmc-group.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240621545202/en/

Clarke McGuire +1 856-638-2807
cmcguire@pmc-group.com

Logo

Tags

More Like This

Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site

Amcor, SK Geo Centric partner for supply of recycled content

PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND

Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky

Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

ARKEMA will be attending this year's JEC edition with A unique portfolio of materials for Composites STAND 5T40 - HALL 5